KPV 10mg & 5mg
A three-amino-acid tripeptide derived from α-melanocyte-stimulating hormone, supplied as 10 mg of sterile lyophilized powder for in-vitro NF-κB and inflammatory-signaling research.
What is KPV?
KPV is a linear tripeptide composed of lysine, proline, and valine (Lys-Pro-Val) — the three C-terminal residues (positions 11–13) of the 13-amino-acid hormone α-melanocyte-stimulating hormone (α-MSH). Unlike the parent hormone, KPV does not engage melanocortin receptors (MC1R to MC5R), yet it retains NF-κB inhibitory activity through a receptor-independent mechanism. This separation of activities is what makes it a useful tool compound for dissecting receptor-dependent from receptor-independent α-MSH biology.
Research areas where laboratories buy KPV for in vitro work include NF-κB pathway-inhibition studies in colonic epithelial cell lines, PepT1 oligopeptide-transporter uptake research, MAPK signaling-suppression assays, and murine colitis models (DSS, TNBS) for damage scoring and cytokine quantification. The peptide is also studied for its antimicrobial activity against Candida albicans and Staphylococcus aureus, retained from the parent α-MSH sequence.
Every lot, independently verified
Compound information
Chemical & structural reference data — specifications, molecular profile and handling.
KPV Mechanism of Action
- Enters cells via PepT1, the proton-coupled di-/tripeptide transporter (reported Km ~160 µM in Caco-2 cells); PepT1 is upregulated in inflamed tissue, amplifying KPV uptake at inflammation sites.
- Competitively disrupts the p65/importin-α3 interaction in the cytoplasm, blocking nuclear translocation of NF-κB in cells exposed to IL-1β or TNF-α.
- Suppresses MAPK signaling at nanomolar concentrations, reducing ERK1/2, JNK, and p38 phosphorylation in stimulated intestinal epithelial cells.
- Does not engage melanocortin receptors (MC1R to MC5R); its activity is receptor-independent.
- Retains the antimicrobial activity of α-MSH against Candida albicans and Staphylococcus aureus in published in-vitro assays.
- Studied in DSS and TNBS murine colitis models, measuring histological scores, cytokine expression, and leukocyte infiltration.
KPV Research Applications
- NF-κB pathway-inhibition studies in colonic epithelial cells (Caco-2, HT29) under inflammatory stimulation.
- PepT1 oligopeptide-transporter research — high-affinity uptake via the proton-coupled transporter upregulated in inflamed tissue.
- MAPK signaling-suppression assays measuring ERK1/2, JNK, and p38 phosphorylation in IL-1β / TNF-α-stimulated cells.
- Murine colitis models (DSS, TNBS) — histological damage scores, cytokine expression, and leukocyte infiltration.
- Antimicrobial-activity studies against Candida albicans, Staphylococcus aureus, and other pathogens.
- Comparative work against the stereoisomer Lys-D-Pro-Val and the related tripeptide K(D)PT to map NF-κB inhibition determinants.
Why Buy KPV from Koi Peptides?
- Every batch of Koi KPV is synthesized and lyophilized in the United States, then released against independent third-party laboratory (Freedom Diagnostics Testing) testing.
- Each lot is tested by HPLC for purity, LC-MS for identity confirmation, and screened for endotoxin before release.
- The lot ID is printed on every vial and ties back to a public COA library, so researchers can verify documentation before they buy and after the vial arrives.
- Orders placed before 2 PM CT ship the same business day, and shipping is free on orders over $200.
References
View all 6 references +
- Dalmasso, G., et al. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134(1), 166–178. doi.org/10.1053/j.gastro.2007.10.026
- Kannengiesser, K., et al. (2008). Melanocortin-derived tripeptide KPV has anti-inflammatory potential. Inflammatory Bowel Diseases, 14(3), 324–331. doi.org/10.1002/ibd.20334
- Brzoska, T., et al. (2008). α-MSH and related tripeptides: anti-inflammatory and protective effects. Endocrine Reviews, 29(5), 581–602. doi.org/10.1210/er.2007-0027
- Catania, A., et al. (2004). Targeting melanocortin receptors as a strategy to control inflammation. Pharmacological Reviews, 56(1), 1–29. doi.org/10.1124/pr.56.1.1
- Cutuli, M., et al. (2000). Antimicrobial effects of α-MSH peptides. J. Leukocyte Biology, 67(2), 233–239. doi.org/10.1002/jlb.67.2.233
- Mandrika, I., et al. (2001). Melanocortin peptides on NF-κB DNA binding and NO production in macrophages. Biochemical Pharmacology, 61(5), 613–621. doi.org/10.1016/S0006-2952(00)00583-7
Regulatory Status
Regulatory status — provided for research context.
Regulatory Status
KPV is not approved by the FDA for any indication. The research-grade material supplied by Koi Peptides is synthesized for laboratory research only; it is not formulated, packaged or labeled as a drug, food or cosmetic.
For laboratory and research use only. Not for human consumption. This product is not a drug, food or cosmetic. It is sold exclusively to qualified researchers and licensed laboratories. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Frequently Asked Questions About KPV
What is KPV used for in research?+
What purity is Koi's KPV?+
What is KPV's relationship to alpha-MSH?+
How does KPV enter cells without a receptor?+
How do I prepare a KPV solution?+
What is the CAS number for KPV?+
How should KPV be stored?+
Is KPV for human use?+
Stock your lab with Koi
Research-grade peptides — made in the USA, third-party tested, with public lot-matched COAs. Shop the catalog, or contact our team with questions.



